Melrose FutureLab Inflammation Modulator 60vc
Melrose FutureLab Inflammation modulator helps to relieve symptoms of mild arthritis and reduces mild joint aches and pains.
This is a premium quality formula featuring Meriva® Curcuma longa phospholipid complex, a patented and clinically trialled form of curcumin.
Melrose FutureLab Inflammation modulator also contains Palmitoylethanolamide (PEA), a fatty acid that belongs to the family of endocannabinoids.
The formula leverages the Phytosomal® active ingredient delivery technology to enhance absorption rates and optimise bioavailability within the body.
Melrose FutureLab Inflammation modulator helps to relieve symptoms of mild arthritis and reduces mild joint aches and pains.
This is a premium quality formula featuring Meriva® Curcuma longa phospholipid complex, a patented and clinically trialled form of curcumin.
Melrose FutureLab Inflammation modulator also contains Palmitoylethanolamide (PEA), a fatty acid that belongs to the family of endocannabinoids.
The formula leverages the Phytosomal® active ingredient delivery technology to enhance absorption rates and optimise bioavailability within the body.
Description
Melrose FutureLab Inflammation modulator helps to relieve symptoms of mild arthritis and reduces mild joint aches and pains.
This is a premium quality formula featuring Meriva® Curcuma longa phospholipid complex, a patented and clinically trialled form of curcumin.
Melrose FutureLab Inflammation modulator also contains Palmitoylethanolamide (PEA), a fatty acid that belongs to the family of endocannabinoids.
The formula leverages the Phytosomal® active ingredient delivery technology to enhance absorption rates and optimise bioavailability within the body.
